← Back
Data updated: Mar 10, 2026
APIL
Pharmaceuticals
APIL is a major pharmaceutical company with 16 FDA-approved products.
1977
Since
16
Drugs
-
Trials
133
Approved (2yr)
Key Drugs
Recent Activity
ATELVIA 2026-02-03
Labeling
ACTONEL 2026-02-03
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2026-01-08
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (13)
Company Info
- First Approval
- 1977-09-01
- Latest
- 2026-02-03
- Applications
- 15